TMToshiki Moriyama

Toshiki Moriyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toshiki Moriyama has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Body Shape Index and Risk of Kidney Function Decline in Older Adults with CKD

    by Takaaki Kosugi, Masahiro Eriguchi, Hisako Yoshida, Hiroyuki Tamaki, Takayuki Uemura, Hikari Tasaki, Riri Furuyama, Masatoshi Nishimoto, Katsuhiko Morimoto, Masaru Matsui, et al.

    Background: A Body Shape Index has recently emerged as a useful obesity marker for predicting adverse events. Although its usefulness has been reported even in older adults, who tend to exhibit the obesity paradox, little evidence is available regarding the association between A Body Shape Index and kidney outcomes. This study aimed to investigate the associations between A Body Shape Index or body mass index (BMI) and kidney outcomes in older adults with CKD. Methods: This nationwide longitudinal observational study included individuals aged 65–74 years with CKD who underwent annual health checkups between 2008 and 2014. Exposures of interest were A Body Shape Index and BMI, and the primary outcome was a 40% decline in estimated glomerular filtration rate (eGFR). The associations between quartiles (Q1–Q4) of A Body Shape Index and BMI and a 40% decline in eGFR were assessed using Cox regression analysis for each sex. Restricted cubic spline analysis was performed to investigate nonlinear associations. The eGFR trajectory across A Body Shape Index categories was evaluated using a mixed-effects model. Results: Among 31,292 men and 23,167 women with CKD, 544 men and 315 women experienced a 40% decline in eGFR during a median follow-up of 26.4 months. Compared to Q1 of A Body Shape Index, Q3 and Q4 were associated with the kidney outcome in men, with adjusted hazard ratios and 95% confidence intervals of 1.32 (1.01–1.71) and 1.72 (1.34–2.21), respectively. The rate of eGFR decline over time was also greater in these categories in men. In contrast, the association between high values of A Body Shape Index and kidney outcomes did not reach statistical significance in women. High BMI was not associated with kidney outcomes in either sex. Conclusions: Higher values of A Body Shape Index were associated with CKD progression in older men in Japan, whereas this association was less evident in women.

  • Open Access

    Sex-specific associations between annual kidney function changes and weight/waist changes in overweight Japanese: Japan Specific Health Checkup cohort

    by Naoki Ozu, Jiro Takeuchi, Kiyoshi Asada, Kunihiro Yamagata, Kunitoshi Iseki, Toshiki Moriyama, Kazuhiko Tsuruya, Shouichi Fujimoto, Ichiei Narita, Tsuneo Konta, et al.

    The impact of changes in obesity-related parameters on kidney functions is unclear. To evaluate the association of body weight (BW) and waist circumference (WC) changes with estimated glomerular filtration rate (eGFR) and proteinuria in obese individuals, we conducted retrospective analysis of the Japan Specific Health Checkup cohort of 664,926 participants (Japanese residents aged 40–74 years) from 2008 to 2011. Participants were classified into nine groups based on BW and WC changes from baseline. Sex differences were stratified. Generalized estimating equations were used to evaluate eGFR changes within each group and the effect of BW or WC changes on eGFR. In a similar manner, the impact of BW and WC changes on the incidence of proteinuria was measured. As a result, total of 20,326 participants with a body mass index of ≥25 kg/m2 and available baseline data, 1-year BW and WC, and 4-year eGFR measurements were included in the analysis. The eGFR slope was –0.59 (95% confidence interval [CI], –0.66 to –0.51). At a threshold change of approximately 5%, compared to the group with unchanged BW and WC, males with decreased BW and WC had improved eGFR at 3 years (1.75; 95% CI, 0.49 to 3.02). Contrastingly, females with increased BW and WC had worsened eGFR at 3 years (–3.44; 95% CI, –6.40 to –0.47). These trends were similar when the thresholds were changed or when the outcome was proteinuria. In conclusion, males with decreasing WC and BW had improved kidney function. Future studies should evaluate specific lifestyle factors.

  • Open Access

    The diagnostic status of chronic kidney disease in a real-world database in Japan: CHECK-CKD

    by Toshiki Moriyama, Keigo Kanafuri, Mayu Kanno, Koji Niibe, Sachiko Nago, Ichiro Fukuoka, Yasuhisa Fukunaga, Issei Doi, Masaru Kawashima

    Background: The clinical practice guidelines for chronic kidney disease (CKD) in 2018 and the launch of the first therapeutic agent in 2021 are expected to have improved CKD management in Japan. However, the reality of CKD diagnosis in this environment is poorly understood. Here, we conducted a retrospective observational study. Methods: We investigated the changes in CKD diagnosis rates, the characteristics of diagnosed cases, and the prognostic impact of the timing of diagnosis by using a database of administrative claims and medical checkups from 2014 to 2023 (DeSC Healthcare Inc.™) for patients with a potential risk of CKD (eGFR 2 and/or urine protein qualitative test result of ≥1+). Results: We extracted 287,999 patients who newly met the diagnostic criteria for CKD at a medical checkup. The rate of new CKD diagnosis remained ~ 3% until 2021. Factors associated with CKD diagnosis included blood/urine tests at a medical institution (odds ratio [OR] 4.11, 95% confidence interval [CI] 3.92–4.31; OR 5.02, 95% CI 4.82–5.22) and presence of comorbidities: anemia (OR 2.30; 95% CI 2.16–2.45), heart failure (OR 1.87; 95% CI 1.76–1.98), and diabetes (OR 1.84; 95% CI 1.76–1.91). The incidence of cardiorenal-related events at 36 months after the date when patients newly met the CKD diagnostic criteria was 4.5% and 12.4% for those diagnosed at stage 3a and 3b, respectively. Conclusions: The prevalence of CKD diagnosis was low and renal function tests were infrequently performed. Periodic blood/urine tests may help clinicians to detect CKD in an early phase. Study registration: UMIN000052393


  • Open Access

    Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

    by Masamitsu Senda, Naohiko Fujii, Toshimitsu Ito, Yoshitaka Isaka, Toshiki Moriyama, Takayuki Hamano

    Reportedly, nausea or vomiting after heavy exercise was associated with post-exercise increased blood calcium (Ca) levels, which was correlated with enhanced bone resorption. We conducted a randomized, double-blind, placebo-controlled trial, enrolling 104 healthy trained male members of the Japan Ground Self-Defense Forces. Risedronate (17.5 mg) or placebo was prescribed 3 and 10 days before heavy exercise lasting approximately 5 h. The primary outcome was the severity of nausea or vomiting assessed by a visual analog scale during or post-exercise. The secondary outcomes included clinical symptoms associated with heat illness, post-exercise serum total Ca (tCa), whole blood ionized Ca (iCa), and serum tartrate-resistant acid phosphatase 5b (TRACP-5b) levels. The mean age was 26 years. The exercise resulted in a 4.5% weight loss. The two groups were comparable in terms of the symptoms, including primary outcome. However, post-exercise tCa and TRACP-5b were significantly lower with risedronate. A similar result was observed for iCa. The post-exercise urinary Ca/Magnesium ratio and the incidence of hypercalcemia (defined as tCa or iCa levels ≥ each median value of all subjects) were significantly lower with risedronate (78.0% vs. 58.5%). A stronger treatment effect of risedronate on blood Ca levels was observed in participants who lost substantial body weight. Post-exercise hypercalcemia is attributed to enhanced bone resorption but not the cause of nausea.

  • Vegetable Preference and Prediction of Proteinuria: A Retrospective Cohort Study

    by Shingo Ozaki, Ryohei Yamamoto, Maki Shinzawa, Ryohei Tomi, Ryuichi Yoshimura, Kaori Nakanishi, Makoto Nishida, Izumi Nagatomo, Takashi Kudo, Keiko Yamauchi-Takihara, et al.

    Introduction: Little information is available about the association between vegetable preference and chronic kidney disease. Methods: This retrospective cohort study included 10,819 university workers in Japan who underwent their annual health checkups between January 2005 and March 2013. According to a question “Do you like vegetables”? with 3 possible answers of “I like vegetables,” “I like vegetables somewhat,” or “I dislike vegetables,” 2,831, 2,249, and 104 male workers and 3,902, 1,648, and 85 female workers were classified into the “like,” “somewhat,” and “dislike” groups, respectively. An association between vegetable preference and incidence of proteinuria (dipstick urinary protein ≥1+) was assessed using Cox proportional-hazards models adjusted for clinically relevant factors. Results: During the median observational period of 5.0 years, the incidence of proteinuria was observed in 650 (12.7%) male and 789 (14.1%) female workers. Among male workers, the “dislike” group had a significantly higher risk of proteinuria (multivariable-adjusted hazard ratio of “like,” “somewhat,” and “dislike” groups: 1.00 [reference], 1.05 [0.90–1.23], and 1.59 [1.01–2.50], respectively). Among female workers, vegetable preference was associated with the incidence of proteinuria in a dose-dependent manner (1.00 [reference], 1.20 [1.04–1.40], 1.95 [1.26–3.02], respectively). Conclusion: “Do you like vegetables”? was a clinically useful tool to identify subjects vulnerable to proteinuria.


  • Exercise-induced hypercalcemia and vasopressin-mediated bone resorption

    by M. Senda, T. Hamano, N. Fujii, T. Ito, Y. Sakaguchi, I. Matsui, Y. Isaka, T. Moriyama

    Summary Our human observational study showed that elevated arginine vasopressin levels by heavy exercise, not catecholamines, were associated with elevated serum tartrate-resistant acid phosphatase 5b (TRACP-5b). The increase in serum calcium was positively associated with percent changes of TRACP-5b, implying the involvement of bone resorption in the pathogenesis of exercise-induced hypercalcemia. Introduction It remains unclear whether enhanced bone resorption explains exercise-induced hypercalcemia. An experimental study demonstrated that arginine vasopressin (AVP) stimulated osteoclast activity. Methods We conducted a prospective observational study, enrolling 65 trained healthy male officers of the Japan Self-Defense Forces (34 and 31 in waves 1 and 2, respectively). Before and after a 5-h heavy exercise, we collected laboratory data including bone markers, symptoms, and ionized calcium (iCa; wave 2 only). As blood calcium levels change after exercise, we estimated calcium (corrected calcium) levels immediately after the exercise using the correlation between blood calcium and time from the end of exercise in another cohort. Results Body weight decreased by 6.9% after the exercise. Corrected post-exercise serum total calcium (tCa) and iCa levels were significantly higher than pre-exercise levels, and 18% of participants showed hypercalcemia defined as corrected tCa >10.4 mg/dL or iCa >1.30 mmol/L. Serum tartrate-resistant acid phosphatase 5b (TRACP-5b), plasma three fractions of catecholamines, and AVP elevated significantly (median 14.3 pg/mL), while procollagen type 1 N-terminal propeptide and whole parathyroid hormone showed significant decreases. Corrected tCa increase showed a non-linear positive association with percent changes of TRACP-5b (%ΔTRACP-5b) even after adjustment for confounders. In addition, %ΔTRACP-5b was not associated with catecholamines, but with post-exercise AVP levels after adjustment for pre-exercise TRACP-5b. Symptoms of nausea or vomiting (observed in 20%) were positively associated with corrected post-exercise iCa after adjustment for post-exercise blood pH. Conclusion AVP elevation may explain bone resorption and the following hypercalcemia in the setting of heavy exercise.


  • Open Access

    SP339NIGHT SHIFT FREQUENCY AND INCIDENCE OF PROTEINURIA: A RETROSPECTIVE COHORT STUDY

    by Ryohei Yamamto, Maki Shinzawa, Yoshiki Kimura, Yoshiyuki Fujii, Katsunori Aoki, Kaori Nakanishi, Masahiro Koseki, Makoto Nishida, Keiko Yamauchi-Takihara, Yoshitaka Isaka, et al.

    INTRODUCTION AND AIMS: Previous studies reported that shift workers were at higher risk of cardiovascular diseases and mortality. However, an association between shift work and chronic kidney disease remain unknown.

  • Open Access

    MP119EFFICACY OF STEROID STEROID THERAPY FOR IGA NEPHROPATHY THERAPY FOR IGA NEPHROPATHY

    by Yasuyuki Nagasawa, Rhouhei Yamamoto, Tatsuya Shouji, Maki Shinzawa, Tomoko Kimura, Kiyiko Yamamoto, Yukiko Hasuike, Katsuyuki Nagatoya, Atsushi Yamauchi, Terumasa Hayashi, et al.

    Introduction and Aims: IgA Nephropathy is most common primary glomerular nephritis not only in Asian, but also in Caucasians. Steroid therapy had been established as standard therapy for IgA nephropathy. But, IgA nephropathy patients with low proteinuria and with normal kidney function were known to have good prognosis. In this point, it is not clear that how much proteinuria and how worse eGFR in IgA nephropathy patients required for the steroid therapy. The aim in this study is to evaluate the relationship between eGFR, proteinuria and efficacy of steroid therapy for IgA nephropathy